Dr Mehdi Mirzazadeh

Professional statement

Dr Mehdi Mirzazadeh is a distinguished consultant in metabolic medicine and chemical pathology based in Epsom. His areas of expertise include metabolic bone disorders such as osteoporosis, metabolic stone management, lipidology, including high cholesterol and triglycerides, medical weight loss, novel biological agents, and interpretation of complex blood tests. His specialist interest is in rare metabolic disorders.

Dr Mirzazadeh is highly qualified, with an MSc in Clinical Biochemistry from King’s College London and an MD from the University of Tehran, ECFMG certificate from United States and also has a BA in Sociology from Azad University. Furthermore, Dr Mirzazadeh holds esteemed fellowship to the Royal College of Pathologists, as well as membership to the Royal College of Physicians.

With a focus on personalised care and evidence-based practice, Dr Mirzazadeh is dedicated to helping patients achieve optimal metabolic health and wellbeing. His extensive training includes higher specialist training in the prestigious Oxford deanery, after which he also undertook collaborative subspecialty training at Cambridge and University College London Hospitals.

His centre of practice is personalised care with an approach to tailoring treatments to individual needs and health goal. He has access to cutting-edge technology to accurately assess metabolic health, including radiological tests like Trabecular Bone Score for bone health, complex omics, including genomics to make diagnosis and direct management in rare and potentially genetic metabolic disorders in addition to complex biochemical tests. He emphasises on a comprehensive approach that considers lifestyle factors, nutrition, and overall well-being. He has publication in and committed to evidence-based practice using proven methods backed by scientific research. He focuses on strategies for sustainable improvements and ongoing support of patients with metabolic diseases with stress on the importance of early intervention and proactive measures to prevent metabolic disorders.bHe incorporates various modalities for a well-rounded treatment approach for a patient and has a dedication to listening to patients' concerns and involving them in decision-making. He has expertise in addressing metabolic issues through lifestyle modifications, including diet and exercise and has had successful diagnosis and management outcomes in cases where the diagnosis was difficult or not obvious.

Currently, Dr Mirzazadeh serves as the clinical lead for metabolic bone disorders at Epsom and St Helier University Hospitals NHS Trust, where he is also the laboratory director for the South West Thames newborn screening services. He is actively involved in teaching undergraduate and supervising postgraduate trainees and holds an honorary senior lecturer post at St George's University of London.

In his additional capacity as an assessor for the national clinical biochemistry quality assurance services, namely, NEQAS, Dr Mirzazadeh leverages his specialist expertise to evaluate specialist advice provided by laboratories around the UK on blood tests concerning calcium and sodium metabolism, vitamin deficiencies, and hormonal imbalances.

He works with GMC in assessing the doctors qualified abroad for the right knowledge and skills to practise in the UK.